Profile
E.
Lynne Kelley is currently the Chief Executive & Medical Officer at Signalexis, Inc. Previously, she held positions as Medical Director at Kimberly-Clark Corp.
and Boston Scientific Corp., Assistant Professor at Yale University, and Vice President-Medical Affairs at Becton, Dickinson & Co. She also served as Chief Medical Officer at Histogenics Corp., Senseonics Holdings, Inc., and X4 Pharmaceuticals, Inc. Kelley received her undergraduate degree from Boston University and her doctorate from Dartmouth Medical School.
E. Lynne Kelley active positions
| Companies | Position | Start |
|---|
Former positions of E. Lynne Kelley
| Companies | Position | End |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2020-04-02 |
| OCUGEN, INC. | Chief Tech/Sci/R&D Officer | 2019-01-22 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 2015-12-31 |
| KIMBERLY-CLARK CORPORATION | Chief Tech/Sci/R&D Officer | 2010-11-30 |
| BOSTON SCIENTIFIC CORPORATION | Chief Tech/Sci/R&D Officer | 2006-12-31 |
Training of E. Lynne Kelley
| Boston University | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| KIMBERLY-CLARK CORPORATION | Consumer Non-Durables |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- E. Lynne Kelley